Compound
Therapy area
Indication
Development stage
Discovery
Preclinical
Phase 1
Phase 2
Phase 3
Golexanolone
Hepatology
Primary biliary cholangitis (PBC)
Hepatic encephalopathy (HE)
GR3049 Potential to be used in a broad spectrum of diseases